Net Income (Quarterly) Chart

View Net Income (Quarterly) for ECVT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Quarterly) Chart
Start Trial

Historical Net Income (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
March 31, 2026 5.746M
December 31, 2025 9.20M
September 30, 2025 0.372M
June 30, 2025 5.986M
March 31, 2025 -8.134M
December 31, 2024 23.80M
September 30, 2024 14.84M
June 30, 2024 8.295M
March 31, 2024 1.221M
December 31, 2023 30.00M
September 30, 2023 16.57M
June 30, 2023 26.12M
March 31, 2023 -1.471M
December 31, 2022 21.50M
September 30, 2022 21.32M
June 30, 2022 19.24M
March 31, 2022 7.875M
December 31, 2021 7.80M
September 30, 2021 4.689M
June 30, 2021 -7.87M
March 31, 2021 -2.748M
Date Value
December 31, 2020 46.00M
September 30, 2020 -22.66M
June 30, 2020 34.32M
March 31, 2020 -3.347M
December 31, 2019 28.40M
September 30, 2019 26.82M
June 30, 2019 30.72M
March 31, 2019 3.441M
December 31, 2018 28.50M
September 30, 2018 14.44M
June 30, 2018 16.16M
March 31, 2018 0.556M
December 31, 2017 65.56M
September 30, 2017 -3.016M
June 30, 2017 -1.67M
March 31, 2017 -2.315M
December 31, 2016 10.53M
September 30, 2016 -9.606M
June 30, 2016 -76.95M
March 31, 2016 -3.131M

Net Income Definition

Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
Olin Corp. -83.00M
Stepan Co. -41.41M
Ascent Industries Co. -1.98M
Solesence, Inc. -0.766M
BioLargo, Inc. -3.405M